The prevalence of clinical and subclinical mammary infections is between 20-40%. As of today, drug treatment in clinical mammary infections consists of antibiotics given during lactation. In cases of subclinical infections, treatment is usually provided upon entry into the dry-off period.
In recent years, awareness of the development of antibiotic-resistant bacteria has led to legislation intended to reduce the use of antibiotics in animal farming. Therefore, there is a great need for alternative treatments, especially a non-antibiotic treatment of mastitis.
From Human Care to Cattle Care
Acoustic Pulse Technology (APT), also known as shockwave treatment, has been widely used in the medical field for more than 20 years, with extremely high success rates in treating patients with a variety of indications in the context of orthopedic, cardiac, vascular and urological pathologies. APT triggers and activates several biological responses, among them angiogenesis and anti-inflammatory response.
A novel APT-based device was developed by ARMENTA specifically to treat dairy cows. It is the first solution of its kind to overcome two major technological barriers to the use of APT in everyday dairy farming, as: 1) the energy is sourced by compressed-air, available in every farm; and 2) a large and deep treatment zone enables rapid application to infected udder tissue (just a few minutes).
Over 70% Recovery and 10% Increased Milk Yield
ARMENTA’s APT treatment was applied successfully to over 600 cows with clinical and subclinical mastitis, and as a preventive measure during the dry-period. The results were clear: over 70% mastitis recovery rates and an increase in milk yield of over 10%, all that was achieved without using antibiotics or other means.